Page last updated: 2024-08-17

levodopa and Leanness

levodopa has been researched along with Leanness in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (50.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Sharma, JC; Vassallo, M	1
Calleja-Castillo, J; Cervantes-Arriaga, A; Corona, T; Morales-Briceño, H; Rodríguez-Violante, M	1
Barry, VC; Klawans, HL	1
Friesen, HG; Pinter, EJ; Tolis, G	1

Reviews

2 review(s) available for levodopa and Leanness

Article	Year
Prognostic significance of weight changes in Parkinson's disease: the Park-weight phenotype. Neurodegenerative disease management, 2014, Volume: 4, Issue:4 Topics: Antiparkinson Agents; Body Weight; Dyskinesia, Drug-Induced; Energy Intake; Female; Humans; Levodopa; Male; Nutritional Status; Parkinson Disease; Quality of Life; Sex Factors; Smell; Thinness; Treatment Outcome; Weight Loss	2014
On the role of dopamine in the pathophysiology of anorexia nervosa. Journal of neural transmission, 1976, Volume: 38, Issue:2 Topics: 17-Ketosteroids; Amphetamine; Anorexia Nervosa; Apomorphine; Compulsive Personality Disorder; Dopamine; Female; Glucose Tolerance Test; Gonadotropins, Pituitary; Humans; Levodopa; Luteinizing Hormone; Male; Movement Disorders; Parkinson Disease; Schizophrenia; Steroids; Thinness	1976

Article

Year

Prognostic significance of weight changes in Parkinson's disease: the Park-weight phenotype.

Neurodegenerative disease management, 2014, Volume: 4, Issue:4

Topics: Antiparkinson Agents; Body Weight; Dyskinesia, Drug-Induced; Energy Intake; Female; Humans; Levodopa; Male; Nutritional Status; Parkinson Disease; Quality of Life; Sex Factors; Smell; Thinness; Treatment Outcome; Weight Loss

2014

On the role of dopamine in the pathophysiology of anorexia nervosa.

Journal of neural transmission, 1976, Volume: 38, Issue:2

Topics: 17-Ketosteroids; Amphetamine; Anorexia Nervosa; Apomorphine; Compulsive Personality Disorder; Dopamine; Female; Glucose Tolerance Test; Gonadotropins, Pituitary; Humans; Levodopa; Luteinizing Hormone; Male; Movement Disorders; Parkinson Disease; Schizophrenia; Steroids; Thinness

1976

Other Studies

2 other study(ies) available for levodopa and Leanness

Article	Year
Overweight is more prevalent in patients with Parkinson's disease. Arquivos de neuro-psiquiatria, 2012, Volume: 70, Issue:11 Topics: Aged; Antiparkinson Agents; Body Mass Index; Case-Control Studies; Dopamine Agents; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Mexico; Middle Aged; Obesity; Overweight; Parkinson Disease; Prevalence; Severity of Illness Index; Thinness	2012
L-dopa, growth hormone and adipokinesis in the lean and the obese. International journal of clinical pharmacology and biopharmacy, 1975, Volume: 12, Issue:1-2 Topics: Blood Glucose; Fatty Acids, Nonesterified; Female; Follicle Stimulating Hormone; Growth Hormone; Humans; Hydrocortisone; Hypopituitarism; Insulin; Levodopa; Lipid Mobilization; Luteinizing Hormone; Male; Obesity; Prolactin; Sex Factors; Thinness	1975

Article

Year

Overweight is more prevalent in patients with Parkinson's disease.

Arquivos de neuro-psiquiatria, 2012, Volume: 70, Issue:11

Topics: Aged; Antiparkinson Agents; Body Mass Index; Case-Control Studies; Dopamine Agents; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Mexico; Middle Aged; Obesity; Overweight; Parkinson Disease; Prevalence; Severity of Illness Index; Thinness

2012

L-dopa, growth hormone and adipokinesis in the lean and the obese.

International journal of clinical pharmacology and biopharmacy, 1975, Volume: 12, Issue:1-2

Topics: Blood Glucose; Fatty Acids, Nonesterified; Female; Follicle Stimulating Hormone; Growth Hormone; Humans; Hydrocortisone; Hypopituitarism; Insulin; Levodopa; Lipid Mobilization; Luteinizing Hormone; Male; Obesity; Prolactin; Sex Factors; Thinness

1975